New PP&P State of Pharmacy Compounding report shows EQUASHIELD ® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...
PORT WASHINGTON, N.Y., April 22, 2026 /PRNewswire/ -- In recognition of Earth Day 2026, EQUASHIELD ®, a global leader in hazardous drug handling, today announced its transition to electronic ...
Equashield, a leading provider of Closed System Transfer Devices (CSTD) for safe and simple handling of hazardous drugs, announced today that it is expanding its range of solutions and products ...
The deal puts Equashield at a valuation of $300 million Equashield was founded in 2009 Since inception in 1989, Nordic Capital has invested more than 20 billion euros in equity capital in over 125 ...
Equashield Remains the Provider of Choice and Most Considered Closed System Transfer Device for Pharmacists and Oncology Nurses in Prevention of Hazardous Drug Exposure A growing number of facilities ...
EQUASHIELD's unique CSTD Syringe Unit features an integrated barrier type pressure equalization system, a leak-preventing dry disconnection mechanism, and an encapsulated closed back syringe with a ...
DUBLIN, May 5, 2021 /PRNewswire/ -- The "Closed System Drug Transfer Device Market Share, Size, Trends, Industry Analysis Report, By Type; By Component; By Closing Mechanism; By Technology; By End-Use ...
As clinicians become more comfortable with the idea of robots in the care setting, more companies are exploring ways to break into the growing hospital robotics market, which is expected to reach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results